A Randomized, Open-Label, Phase 3 Study of Acalabrutinib in Combination with Rituximab and Reduced Dose CHOP (R-miniCHOP) in Older Adults with Untreated Diffuse Large B-Cell Lymphoma (ARCHED / GLA 2022-1) Konstantinos Christofyllakis , Viola Poeschel , Bettina Altmann , Stephanie Maurer , Vadim Lesan , Joerg Bittenbring , Igor Age Kos , Dominic Kaddu-Mulindwa , Zanir Abdi , Octavian Fleser , Sarah Altmeyer , Nina Rosa Neuendorff , Maike Nickelsen , Gerhard Held , Martin Dreyling , Florian Zettl , Christian Buske , Georg Lenz , Bertram Glass , Bjoern Chapuy , Norbert Schmitz , Theodoros Vassilakopoulos , German Ott , Reiner Siebert , Andreas Viardot , Florian Scherer , Roland Schmitz , Andreas Rosenwald , Dirk Hellwig , Markus Loeffler , Stephan Stilgenbauer , Lorenz Thurner , Moritz Bewarder , Marita Ziepert BLOOD（2023）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
